An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
This study has been terminated.
Study NCT00355901
Information provided by Facet Biotech
First Received on July 21, 2006.
Last Updated on August 2, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
